|
Pfizer Announces Primary Endpoints Met in Second Phase 3 Clinical Trial of Tofacitinib
|
06 March 2011 |
|
New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin
|
13 February 2011 |
|
Pfizer To Acquire Ferrosan's Consumer Healthcare Business
|
07 February 2011 |
|
New Co-Promotion Agreements For Rheumatoid Arthritis Products In Japan
|
06 February 2011 |
|
Pfizer Reports Fourth-Quarter and Full-Year 2010 Results
|
01 February 2011 |
|
Pfizer Completes Tender Offer For Shares Of King Pharmaceuticals, Inc.
|
31 January 2011 |
|
Pfizer Submits Applications to Expand the Use of Prevnar 13® to Adults 50 and Older
|
22 December 2010 |
|
Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.
|
15 December 2010 |
|
Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine
|
12 December 2010 |
|
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
|
06 December 2010 |
|
Pfizer Launches Global Centers for Therapeutic Innovation
|
18 November 2010 |
|
Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity
|
15 November 2010 |
|
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent
|
09 November 2010 |
|
Pfizer Reports Third-Quarter 2010 Revenues of $16.2 Billion
|
03 November 2010 |
|
Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
|
28 October 2010 |
|
Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
|
22 October 2010 |
|
Biocon and Pfizer Enter Into Global Commercialization Agreement
|
20 October 2010 |
|
Results from a national survey of Alzheimer's Disease
|
15 October 2010 |
|
Pfizer to Acquire King Pharmaceuticals, Inc.
|
13 October 2010 |
|
Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
|
28 September 2010 |